Exposure to antibiotics during pregnancy alters offspring outcomes

Wenhao Qu1,2, Linsheng Liu1, Liyan Miao1,2

  • 1Department of Pharmacy, The First Affiliated Hospital of Soochow University, Suzhou, China.

Insights

Maternal antibiotic use during pregnancy impacts infant gut microbiome development and health outcomes. These microbiome alterations may offer protective effects and novel therapeutic targets for children later in life.

Area of Science:

  • Microbiome research
  • Perinatal health
  • Pediatric disease

Background:

  • Microbial composition is integral to human health.
  • Antibiotic exposure in pregnancy can negatively impact the neonatal gut microbiome.
  • This may lead to adverse infant development, including allergies, metabolic and brain disorders, and infections.

Purpose of the Study:

  • To review the effects of maternal antibiotic use during pregnancy on offspring health.
  • To explore potential disease risks in animal and human offspring.

Main Methods:

  • Literature review of studies on maternal antibiotic exposure and offspring outcomes.
  • Analysis of animal and human data.

Main Results:

  • Antibiotic exposure during pregnancy demonstrably alters offspring development.
  • Changes in the microbiome composition were observed.

Conclusions:

  • Maternal antibiotic use during pregnancy has lasting effects on offspring.
  • Microbiome alterations present potential protective benefits and future therapeutic avenues for pediatric conditions.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.1K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
566
Antibiotic Selection00:57

Antibiotic Selection

Overview
56.7K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
43
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.6K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
37